Tag Archives: Cam Battley

Cam Battley: CanniMed Shareholders Should Tender Their Shares to Aurora

Cam Battley: CanniMed Shareholders Should Tender Their Shares to Aurora

Cam Battley: CanniMed Shareholders Should Tender Their Shares to Aurora

Aurora Cannabis has launched the first ever “hostile” takeover of another ACMPR Licensed Producer of Medical Marijuana. Executive Vice President Cam Battley lays out the case for why CanniMed shareholders should tender their shares to the Aurora bid.

Aurora Cannabis operational update

Operational Update: Aurora Cannabis Surpasses 19,000 Patients; Record Monthly Revenue, Shipments, Grams Sold

VANCOUVER, Aug. 31, 2017 /Weed Wire/ – Aurora Cannabis Inc. (“Aurora” or the “Company”) (TSX: ACB) (OTCQX: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) is pleased to provide the following operational update.

Aurora Cannabis eyes expansion with legalization on the horizon

Aurora Cannabis Eyes Expansion With Legalization on the Horizon

As Canada heads toward legalization of marijuana, Alberta producer Aurora Cannabis is focused on expansion with ambitions to raise a $160-million “war chest” from investors who are anxious to profit from what is expected to be a multibillion industry.

Aurora Cannabis operational update

Aurora Completes Acquisition of Peloton Pharmaceuticals Inc.

VANCOUVER, British Columbia, April 4, 2017 /Weed Wire/ – Aurora Cannabis Inc. (the “Company” or “Aurora”) (TSXV: ACB) (OTCQX: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) is pleased to announce that, further to its press release of March 6, 2017, the Company has completed the acquisition of Peloton Pharmaceuticals Inc. (“Peloton”), a Montreal-area late-stage ACMPR-applicant.

Aurora Cannabis operational update

Aurora Cannabis to be Cornerstone Investor in Australian Medical Cannabis IPO

VANCOUVER, March 28, 2017 /Weed Wire/ — Aurora Cannabis Inc. (the “Company” or “Aurora”) (TSXV: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) is pleased to announce that it has committed to taking part in the initial public offering (“IPO”) of Cann Group Limited (“Cann Group”) on the Australian Stock Exchange (“ASX”) as the cornerstone investor.

Aurora Cannabis operational update

Aurora Cannabis Appoints Neil Belot Chief Global Business Development Officer

VANCOUVER, British Columbia, March 21, 2017 /Weed Wire/ — Aurora Cannabis Inc. (the “Company” or “Aurora”) (TSXV: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) is pleased to announce that Neil Belot has been promoted to Chief Global Business Development Officer.

Aurora Cannabis operational update

Aurora to Acquire Peloton Pharmaceuticals Inc.

VANCOUVER, British Columbia, March 6, 2017 /Weed Wire/ — Aurora Cannabis Inc. (the “Company” or “Aurora”) (TSXV: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) is pleased to announce that its proposal (the “Proposal”) to acquire Peloton Pharmaceuticals Inc. out of bankruptcy protection was approved by Peloton’s creditors at a recent meeting (the “Creditor Meeting”).

Aurora Cannabis operational update

Aurora Cannabis Expands E-commerce Strategy With Launch of Second Generation Mobile App

VANCOUVER, British Columbia, March 1, 2017 /Weed Wire/ — Aurora Cannabis Inc. (the “Company” or “Aurora”) (TSXV: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM), today unveiled the second generation of its popular mobile application, incorporating a number of enhanced features to provide a significantly upgraded user experience to new and existing clients of the Company.

Aurora Cannabis operational update

Aurora Receives Health Canada License to Sell Cannabis Oils

VANCOUVER, British Columbia, Jan. 23, 2017 /Weed Wire/ — Aurora Cannabis Inc. (the “Company” or “Aurora”) (TSXV: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) is pleased to announce that on January 20, 2017, its wholly-owned subsidiary, Aurora Cannabis Enterprises Inc., a licensed producer and distributor of medical cannabis, was licensed by Health Canada for the sale of cannabis oils.

Aurora Cannabis operational update

Operational Update: Aurora Cannabis Surpasses 12,000 Registered Patients in First 12 Months of Product Sales

VANCOUVER, British Columbia, Jan. 16, 2017 /Weed Wire/ — Aurora Cannabis Inc. (“Aurora” or the “Company”) (TSXV: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) is pleased to provide the following operational update.

Aurora Cannabis operational update

Aurora Announces Conversion of $15 Million Debentures

VANCOUVER, British Columbia, Oct. 20, 2016 /Weed Wire/ — Aurora Cannabis Inc. (the “Company” or “Aurora”) (TSXV: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) announced today that the Company has elected to exercise its right under the indenture (the “Indenture”) governing the Company’s 10.0% unsecured convertible debentures.

Aurora Cannabis operational update

Aurora Appoints Joseph del Moral to Board of Directors

VANCOUVER, Oct. 6, 2016 /Weed Wire/ — Aurora Cannabis Inc. (the “Company” or “Aurora” or the “Issuer”) (TSXV: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) announced today that Mr. Joseph del Moral has been appointed to the Company’s Board of Directors.

Aurora Cannabis operational update

Aurora Completes $15 Million Debenture Offering, Improves Balance Sheet by Replacing High Interest Secured Debt

VANCOUVER, British Columbia, Sept. 28, 2016/Weed Wire/ — Aurora Cannabis Inc. (the “Company” or “Aurora”) (CSE: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) is pleased to announce, further to its news release dated September 16, 2016, that it has completed the brokered private placement.

Aurora Cannabis operational update

Aurora Cannabis to Acquire CanvasRx, Closes $23 Million Financing, Monthly Gross Revenue Surpasses $1 Million – Video Available on Investmentpitch.com

VANCOUVER, Aug. 12, 2016 /Weed Wire/ — Aurora Cannabis (CSE: ACB) (OTCQB: ACBFF) (FSE: 21P), has entered into a definitive agreement to acquire CanvasRx Inc. from CanvasRx Holdings Inc.

Aurora Cannabis operational update

Aurora Cannabis Closes $23 Million Financing and Signs Definitive Agreement to Acquire CanvasRx

VANCOUVER, Aug. 10, 2016 /Weed Wire/ — Aurora Cannabis Inc. (the “Company” or “Aurora”) (CSE: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) is pleased to announce that it has entered into a definitive share purchase agreement with CanvasRx Holdings Inc. to acquire (the “Acquisition”) all of the issued and outstanding shares of CanvasRx Inc.

Aurora Cannabis operational update

Aurora Announces Terms and Increase of Brokered Private Placement to $18 Million

VANCOUVER, British Columbia, July 18, 2016 /Weed Wire/ — Aurora Cannabis Inc. (CSE: ACB) (OTCQB: ACBFF) is pleased to announce, further to its news release dated June 8, 2016, the pricing terms, and an increase in the size of its best efforts private placement offering of subscription receipts.

Aurora Cannabis operational update

Aurora to Acquire CanvasRx, Uniting One of the Fastest Growing Cannabis Producers and Canada’s Largest Cannabis Patient Counselling Service

VANCOUVER, June 8, 2016 /Weed Wire/ — Aurora Cannabis Inc. – (the “Company” or “Aurora”) (CSE: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) is pleased to announce that it has entered into a letter of intent (the “LOI”) to acquire (the “Acquisition”) all of the issued and outstanding shares of CanvasRx Inc. (“CanvasRx”).

Aurora Cannabis operational update

Aurora Enters Into $5 Million Equity Facility With New York Private Equity Firm Alumina Partners LLC

VANCOUVER, June 6, 2016 /Weed Wire/ — Aurora Cannabis Inc. – (the “Company” or “Aurora”) (CSE – “ACB”) (OTCQB – “ACBFF”) (Frankfurt: 21P; WKN: A1C4WM) is pleased to announce that on June 3, 2016, the Company entered into a non-binding agreement for a draw-down equity facility of up to $5,000,0000.

Aurora Cannabis operational update

Aurora Announces Q3 2016 Results

VANCOUVER, British Columbia, May 30, 2016 /Weed Wire/ — Aurora Cannabis Inc. (CSE:ACB)(FRANKFURT:21P)(WKN:A1C4WM)(OTCQB:ACBFF) (“Aurora” or the “Company”) announced its financial and operational results for the three and nine month periods ended March 31, 2016. Aurora is a Licensed Producer of medical cannabis under Health Canada’s Marihuana for Medical Purposes Regulations (MMPR).

Aurora Cannabis operational update

Aurora Launches Same-Day Medical Marijuana Delivery in Calgary

VANCOUVER, British Columbia, May 24, 2016 /Weed Wire/ — Aurora Cannabis Inc. (CSE:ACB)(FRANKFURT: 21P)(OTCQB: ACBFF)(WKN: A1C4WM) (“Aurora” or the “Company”), is pleased to announce that the Company has launched same-day delivery of medical cannabis orders to registered customers in Calgary and surrounding communities, an area encompassing a population of 1.2 million people.

Aurora Cannabis operational update

Aurora Cannabis Provides Operational Update

VANCOUVER, British Columbia, April 1, 2016 /Weed Wire/ — Aurora Cannabis Inc. (CSE:ACB)(FRANKFURT:21P)(OTCQB:ACBFF) (WKN:A1C4WM) (“Aurora” or the “Company”), a Licensed Producer of medical cannabis under Health Canada’s Marihuana for Medical Purposes Regulations (MMPR), is pleased to provide the following operational update…

bedrocan canada

Bedrocan Canada and Tweed Announce Multi-centre Longitudinal Surveillance Study of Medical Cannabis Patients

TORONTO, Sept. 17, 2015 /CNW/ – Bedrocan Canada Inc. (“Bedrocan” or the “Company”), a subsidiary of Tweed Marijuana Inc. (TSXV: TWD) (“TMI” or “Tweed”), along with its sister company Tweed Inc., is pleased to announce the launch of the EQUAL (Evaluation QUAlity of Life) study.

bedrocan canada

Bedrocan Domestic Production Facility Is Fully-Licensed by Health Canada

TORONTO, Aug. 24, 2015 /CNW/ – Bedrocan Cannabis Corp. (TSXV: BED) (“the Company” or “Bedrocan”) announced today that it has received a license amendment from Health Canada, whereby the Company’s domestic production facility is now fully-licensed.


Top